Perforator Stroke After Elective Stenting of Symptomatic Intracranial Stenosis
Neurol 66:1868-1872,1803, Jiang,W.,et al, 2006
The Thalamus and Behavior. Effects of Anatomically Distinct Strokes
Neurol 66:1817-1823, Carrera,E. &Bogousslavsky,., 2006
Multifocal Axonal Polyneuropathy in Celiac Disease
Neurol 66:1923-1925, Chin,R.L.,et al, 2006
The Clinical Features, MRI Findings, and Outcome of Optic Neuritis in Children
Neurol 67:258-262, Wilejto,M.,et al, 2006
Practice Parameter: Prediction of Outcome in Comatose Survivors After Cardiopulmonary Resuscitation (An Evidence-Based Review).
Neurol 67:203-210, Wijdicks,E.F.M.,et al, 2006
Neurological Outcome of Septic Cardioembolic Stroke After Infective Endocarditis
Stroke 37:2094-2099, Ruttmann,E.,et al, 2006
Incidence, Cause, and Short-Term Outcome of Convulsive Status Epilepticus in Childhood: Prospective Population-Based Study
Lancet 368:222-229, Chin,R.F.M.,et al, 2006
Evolution of Cerebral Arteriopathies in Childhood Arterial Ischemic Stroke
Ann Neurol 59:620-626, Danchaivijitr,N.,et al, 2006
Plasma D-Dimer Predicts Poor Outcome After Acute Intracerebral Hemorrhage
Neurol 67:94-98, Delgado,P.,et al, 2006
A Modified Peripheral Neuropathy Scale: The Overall Neuropathy Limitations Scale
JNNP 77:973-976,899, Graham,R.C. &Hughes,R.A.C., 2006
Subarachnoid Haemorrhage in Patients =75 Years: Clinical Course, Treatment and Outcome
JNNP 77:933-937,900, Nieuwkamp,D.J.,et al, 2006
Significance of T2 Lesions in Multiple Sclerosis: A 13-Year Longitudinal Study
Ann Neurol 60:236-242, Rudick,R.A.,et al, 2006
Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006
Subarachnoid Haemorrhage
BMJ 333:235-240, Al-Shahi,R.,et al, 2006
GAMT Deficiency: Features, Treatment, and Outcome in an Inborn Error of Creatine Synthesis
Neurol 67:480-484, Mercimek-Mahmutoglu,S.,et al, 2006
Intracerebral Hemorrhage in Pregnancy: Frequency, Risk Factors, and Outcome
Neurol 67:424-429, Bateman,B.T.,et al, 2006
In Utero Antiepileptic Drug Exposure: Fetal Death and Malformations
Neurol 67:407-412, Meador,K.J.,et al, 2006
Cognitive Effects of Lamotrigine Compared With Topiramate in Patients With Epilepsy
Neurol 67:400-406, Blum,D.,et al, 2006
Factors Associated With Poor Compliance of Patients with Epilepsy Driving Restrictions
Neurol 67:869-871, Polychronopoulos,P.,et al, 2006
Characteristics and Antecedents of Progressive Multifocal Leukoencephalopathy in an Insured Population
Neurol 67:884-886, Eng,P.M.,et al, 2006
Factors Predicting Prognosis After Decompressive Hemicraniectomy for Hemispheric Infarction
Neurol 67:891-893, Rabinstein,A.A.,et al, 2006
Cerebral Venous Sinus Thrombosis: Incidence of Venous Thrombosis Recurrence and Survival
Neurol 67:814-819, Gosk-Bierska,I.,et al, 2006
Distribution and Outcome of Symptomatic Stenoses and Occlusions in Patients With Acute Cerebral Ischemia
Arch Neurol 63:1287-1291, Weimar,C.,et al, 2006
Myocardial Injury and Long-Term Mortality Following Moderate to Severe Carbon Monoxide Poisoning
JAMA 295:398-402, Henry,C.R.,et al, 2006
Causes of Death Among Patients with Myasthenia Gravis in Norway Between 1951 and 2001
JNNP 77:203-207, Owe,J.F.,et al, 2006
Sudden Unexpected Death in Epilepsy (SUDEP): Dont Ask, Dont Tell?
JNNP 77:199-202, Morton,B.,et al, 2006
Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients, An Analysis of the Nationwide Inpatient Sample 1999 to 2002
Stroke 37:440-446, Bateman,B.T.,et al, 2006
The Hyperdense Posterior Cerebral Artery Sign
Stroke 37:399-403, Krings,T.,et al, 2006
Recent Advances in the Diagnosis and Management of Migraine
BMJ 332:25-29, Goadsby,P.J., 2006
First Symptom in Sporadic Creutzfeldt-Jakob Disease
Neurol 66:286-287, Rabinovici,G.D.,et al, 2006
Seizures and Their Outcome in Progressive Multifocal Leukoencephalopathy
Neurol 66:262-264, Lima,M.A.,et al, 2006
Multiple-Level Studies Are Needed to Assess the True Value of Diagnostic Tests for Dementia
Arch Neurol 63:142-143,146, Van Gool,W.A., 2006
Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006
Prediction of Poor Outcome Within the First 3 Days of Postanoxic Coma
Neurol 66:62-68, Zandbergen,E.G.J.,et al, 2006
Cerebellar Infarction int he Territory of the Medial Branch of the Superior Cerebellar Artery
Neurol 66:115-117, Sohn,S.-I.,et al, 2006
Community-Acquired Bacterial Meningitis in Adults
NEJM 354:44-53, van de Beek,D.,et al, 2006
Presentation of Intracerebral Haemorrhage in a Community
JNNP 77:340-344, Zahuranec,D.B.,et al, 2006
Clinical Study of 39 Patients with Atypical Lacunar Syndrome
JNNP 77:381-384, Arboix,A.,et al, 2006
Epilepsy in Children
Lancet 367:499-524, Guerrini,R., 2006
Fatal Fat Embolism after Vertebroplasty:Identification of the High-Risk Patient
AJNR 27:343-345, Syed,M.I.,et al, 2006
CSF Findings in 250 Patients with Serologically Confirmed West Nile Virus Meningitis and Encephalitis
Neurol 66:361-365, Tyler,K.L.,et al, 2006
Incidence and Causes of Nondegenerative Nonvascular Dementia
Arch Neurol 63:218-221, Knopman,D.S.,et al, 2006
Left Insular Stroke is Associated with Adverse Cardiac Outcome
Neurol 66:477-483, Laowattana,S.,et al, 2006
Internal and Cortical Border-Zone Infarction, Clinical and Diffusion-Weighted Imaging Features
Stroke 37:841-846, Yong,S.W.,et al, 2006
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006
Cerebral Microhemorrhages Predict New Disabling or Fatal Strokes in Patients with Acute Ischemic Stroke or Transient Ischemic Attack
Stroke 37:911-914, Boulanger,J-M.,et al, 2006
Therapy of Basilar Artery Occlusion, A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis
Stroke 37:922-928, Lindsberg,P.J.&Mattle,H.P., 2006
Metabolic Disease and Stroke: MELAS
emedicine.com, Mandava,P.,et al, 2006
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006